Paul D. Barone
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Paul D.
Contact Paul D., search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck RackActions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Articles
Wild-type p53 overexpression in NPM1-mutated acute myeloid leukemia: potential implications for disease biology and therapy response
In the latest World Health Organization (WHO) and International Consensus Classification (ICC) diagnostic schema for hematolymphoid neoplasms acute myeloid leukemias (AML) are now largely genetically-defined.1,2 At seemingly opposite ends of the clinicopathologic and genomic spectra lie AML with mutated NPM1 (NPM1-AML) and AML (and precursor states) harboring TP53 abnormalities (TP53-AML).
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Paul D.
Contact Paul D., search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack